Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Camcevi Generic Name & Formulations
Legal Class
Rx
General Description
Leuprolide mesylate 42mg; per prefilled syringe; emulsion for SC inj.
Pharmacological Class
GnRH analogue.
How Supplied
Kit—1 (w. supplies)
Manufacturer
Generic Availability
NO
Camcevi Indications
Indications
Advanced prostate cancer.
Camcevi Dosage and Administration
Adult
Give by SC inj on the upper- or mid-abdominal area. Avoid areas with brawny or fibrous tissue or locations that could be rubbed or compressed. 42mg once every 6months.
Children
Not established.
Camcevi Contraindications
Contraindications
Hypersensitivity to GnRH analogues.
Camcevi Boxed Warnings
Not Applicable
Camcevi Warnings/Precautions
Warnings/Precautions
May worsen metastatic vertebral lesions and/or urinary tract obstruction; monitor closely during first few weeks. Increased risk of diabetes, MI, sudden cardiac death, stroke. Monitor blood glucose, HbA1c, and for CVD signs/symptoms during therapy. Risk of QT prolongation in those with congenital long QT syndrome, CHF, or frequent electrolyte abnormalities. Correct and monitor electrolyte abnormalities; consider monitoring ECGs. Monitor serum testosterone levels post-inj. Embryo-fetal toxicity. Pregnancy. Nursing mothers: not recommended.
Camcevi Pharmacokinetics
See Literature
Camcevi Interactions
Interactions
Caution with concomitant drugs known to prolong the QT interval.
Camcevi Adverse Reactions
Adverse Reactions
Hot flush, hypertension, inj site reactions, upper respiratory tract infections, musculoskeletal pain, fatigue, pain in extremity; spinal cord compression, hyperglycemia, convulsions.
Camcevi Clinical Trials
See Literature
Camcevi Note
Not Applicable
Camcevi Patient Counseling
See Literature
